Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo-Reference-Cited by-同舟云学术

Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo

Published:2015-01-01 Issue:1 Volume:151 Page:42
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Lim Henry W.¹,Grimes Pearl E.²,Agbai Oma³,Hamzavi Iltefat¹,Henderson Marsha¹,Haddican Madelaine⁴,Linkner Rita V.⁴,Lebwohl Mark⁴

Affiliation:

1. Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan

2. Vitiligo and Pigmentation Institute of Southern California, Los Angeles

3. Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan3Department of Dermatology, University of California, Davis, Sacramento

4. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences;Journal of the European Academy of Dermatology and Venereology;2024-09-11

2. Integrative Genetics and Multiomics Analysis Unveil Mechanisms and Therapeutic Targets in Vitiligo: Insights from GWAS-meta, Microarray, Single-cell Transcriptomics, and ChIP-seq Data, Highlighting JAK/STAT Pathway Regulation of CTSS in Vitiligo;2024-09-08

3. Vitiligo: From Pathogenesis to Treatment;Journal of Clinical Medicine;2024-09-03

4. Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications;Journal of Clinical Medicine;2024-08-20

5. Up-and-Coming Drugs for the Treatment of Vitiligo;ANN DERMATOL;2024